Russian

OÜ Cambrex Tallinn

10396298

Информация о компании

OÜ Cambrex Tallinn

10396298

Адрес

Часть города Мустамяэ, Teaduspargi tn 3/1, 12618, Харьюмаа, Эстония

Электронный адрес

[email protected]

Телефонный номер

+372 58845642

Веб-сайт

www.cambrex.com
Homehttps://www.cambrex.comHome

Cambrex is a global contract development and manufacturing organization (CDMO) offering drug substance, drug product and analytical services.

https://cambrex.com/about-us/https://cambrex.com/locations/https://careers.cambrex.com/https://cambrex.com/news/https://cambrex.com/events/https://cambrex.com/insights-resources/https://cambrex.com/meet-our-experts/https://cambrex.com/drug-substance/https://cambrex.com/drug-substance/ind-enabling-services/https://cambrex.com/drug-substance/custom-api-development/https://cambrex.com/drug-substance/custom-api-development/process-development/https://cambrex.com/drug-substance/custom-api-development/api-analytical-development/https://cambrex.com/drug-substance/custom-api-development/process-safety/https://cambrex.com/drug-substance/custom-api-development/portfolio-optimization/https://cambrex.com/drug-substance/custom-api-manufacturing/https://cambrex.com/drug-substance/custom-api-manufacturing/clinical-api-manufacturing/https://cambrex.com/drug-substance/custom-api-manufacturing/commercial-api-manufacturing/https://cambrex.com/drug-substance/generic-api-manufacturing/https://cambrex.com/drug-substance/generic-api-manufacturing/product-catalog/https://cambrex.com/drug-substance/generic-api-manufacturing/advanced-gmp-intermediates-and-rsms/https://cambrex.com/drug-substance/peptides/https://cambrex.com/drug-substance/peptides/custom-peptide-synthesis/https://cambrex.com/drug-substance/peptides/peptide-crystallization/https://cambrex.com/drug-substance/api-technology-transfer/https://cambrex.com/drug-substance/specialty-solutions/https://cambrex.com/drug-substance/specialty-solutions/biocatalysis/https://cambrex.com/drug-substance/specialty-solutions/continuous-flow/https://cambrex.com/drug-substance/specialty-solutions/controlled-substances/https://cambrex.com/drug-substance/specialty-solutions/small-scale-commercial-manufacturing/https://cambrex.com/drug-substance/specialty-solutions/in-line-analytics/https://cambrex.com/drug-substance/specialty-solutions/highly-potent-apis/https://cambrex.com/drug-substance/specialty-solutions/crystallization-process-development/https://cambrex.com/drug-substance/specialty-solutions/complex-synthetics/https://cambrex.com/drug-substance/specialty-solutions/continuous-process-technologies/https://cambrex.com/drug-substance/reactor-build-and-design/https://cambrex.com/analytical-services/https://cambrex.com/analytical-services/analytical-testing/https://cambrex.com/analytical-services/analytical-testing/method-development-validation/https://cambrex.com/analytical-services/analytical-testing/release-ich-stability-testing/https://cambrex.com/analytical-services/analytical-testing/material-characterization/https://cambrex.com/analytical-services/analytical-testing/elemental-impurities/https://cambrex.com/analytical-services/analytical-testing/compendial-testing/https://cambrex.com/analytical-services/analytical-testing/impurity-identification/https://cambrex.com/analytical-services/analytical-testing/nitrosamine-testing/https://cambrex.com/analytical-services/analytical-testing/extractables-and-leachables-testing/https://cambrex.com/analytical-services/analytical-testing/reference-standards/https://cambrex.com/analytical-services/analytical-testing/in-use-studies/https://cambrex.com/analytical-services/analytical-testing/environmental-monitoring/https://cambrex.com/analytical-services/microbiology/https://cambrex.com/analytical-services/microbiology/antimicrobial-effectiveness-and-antibiotic-testing/https://cambrex.com/analytical-services/microbiology/bioburden-testing/https://cambrex.com/analytical-services/microbiology/container-closure-integrity-testing/https://cambrex.com/analytical-services/microbiology/disinfectant-qualification/https://cambrex.com/analytical-services/microbiology/endotoxin-testing/https://cambrex.com/analytical-services/microbiology/filter-testing/https://cambrex.com/analytical-services/microbiology/incubation-studies/https://cambrex.com/analytical-services/microbiology/microbial-enumeration-testing/https://cambrex.com/analytical-services/microbiology/microbial-identification/https://cambrex.com/analytical-services/microbiology/mycoplasma-and-biological-reactivity-testing/https://cambrex.com/analytical-services/microbiology/sterility-testing-and-validation/https://cambrex.com/analytical-services/microbiology/water-testing/https://cambrex.com/analytical-services/solid-state-chemistry/https://cambrex.com/analytical-services/stability-storage/https://cambrex.com/drug-product/https://cambrex.com/drug-product/formulation-development/https://cambrex.com/drug-product/clinical-trial-manufacturing/https://cambrex.com/solutions-by-phase/https://cambrex.com/solutions-by-phase/early-phase-solutions/https://cambrex.com/solutions-by-phase/late-phase-solutions/https://cambrex.com/solutions-by-phase/commercial-solutions/https://cambrex.com/news/cambrex-unveils-120-million-investment-to-expand-api-manufacturing-and-strengthen-u-s-drug-supply-resilience/https://cambrex.com/contact/https://cambrex.com/legal/privacy-policy/https://cambrex.com/about-us/recruitment-policy/https://cambrex.com/forms-and-certificates/https://cambrex.com/legal/https://cambrex.com/snapdragon-chemistryhttps://linkedin.com/company/cambrex

Общая информация

Название

OÜ Cambrex Tallinn

Регистрационный код

10396298

Номер НДС

EE100145027

Тип

OÜ - Общество с ограниченной ответственностью

Статус

Зарегистрирована

Дата основания

02.03.1998 (27)

Финансовый год

01.01-31.12

Капитал

51 120.00 €

Деятельность

72101 -

Доход

3 713 273 €

Прибыль

359 068 €

Рентабельность

10%

Валовая зарплата

2 779 €

(оценка приблизительная)

Собственный капитал

2 158 031 €

Сотрудники

-

Годовой отчет

Представлено

Налоговые задолженности

Нет налоговых задолженностей

Рентабельность собственного капитала

17%

Рентабельность активов

15%

Финансовая информация

2019
12.03.2020 		2020
29.04.2021 		2021
10.05.2022 		2022
01.06.2023 		2023
21.06.2024 		2024
30.06.2025
Общий доход 2 145 218 € 2 229 023 € 2 350 292 € 2 862 636 € 3 587 180 € 3 713 273 €
Чистая прибыль (убыток) за период 165 257 € 84 320 € 98 020 € 65 916 € 316 363 € 359 068 €
Рентабельность 8% 4% 4% 2% 9% 10%
Оборотные активы 706 400 € 617 677 € 654 877 € 732 054 € 567 536 € 1 149 038 €
Внеоборотные активы 719 340 € 888 893 € 952 232 € 1 028 886 € 1 558 083 € 1 325 296 €
Общие активы 1 425 740 € 1 506 570 € 1 607 109 € 1 760 940 € 2 125 619 € 2 474 334 €
Краткосрочные обязательства 191 396 € 187 906 € 190 425 € 278 340 € 326 656 € 316 303 €
Долгосрочные обязательства - - - - - -
Общие обязательства - - - - - -
Уставной капитал 51 120 € 51 120 € - - - -
Собственный капитал 1 234 344 € 1 318 664 € 1 416 684 € 1 482 600 € 1 798 963 € 2 158 031 €
Сотрудники 33 34 39 45 48 46

Уплаченные налоги, облагаемый оборот и количество сотрудников

Оборот
Государственные налоги
Трудовые налоги и платежи
Сотрудники
2025 Q4 896 177 € 196 525 € 211 292 € 40
2025 Q3 652 498 € 195 596 € 210 663 € 40
2025 Q2 975 054 € 215 917 € 232 099 € 41
2025 Q1 793 092 € 198 419 € 212 420 € 40
2024 Q4 1 343 459 € 190 560 € 203 361 € 42
2024 Q3 691 133 € 192 396 € 205 371 € 42
2024 Q2 908 690 € 213 676 € 227 902 € 44
2024 Q1 779 070 € 205 919 € 219 901 € 47
2023 Q4 995 782 € 213 123 € 227 425 € 48
2023 Q3 864 002 € 203 633 € 217 863 € 48
2023 Q2 964 685 € 212 717 € 227 624 € 48
2023 Q1 797 595 € 185 421 € 198 129 € 47
2022 Q4 806 115 € 176 582 € 188 455 € 44
2022 Q3 595 050 € 163 770 € 175 729 € 44
2022 Q2 794 231 € 178 101 € 190 986 € 42
2022 Q1 629 329 € 150 819 € 161 659 € 40